Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases

BACKGROUND: Bevacizumab, an anti–vascular endothelial growth factor antibody, has been used for the treatment of radiation necrosis. Thus far, however, there has been no definitive report on its use for the treatment of symptomatic pseudoprogression. Here we report 2 cases of successful treatment wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Miyatake, Shin-Ichi, Furuse, Motomasa, Kawabata, Shinji, Maruyama, Takashi, Kumabe, Toshihiro, Kuroiwa, Toshihiko, Ono, Koji
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2013
Materias:
Case Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3661101/
https://ncbi.nlm.nih.gov/pubmed/23460324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares